OMAPiX Announces Strategic Partnerships with Leading Spatial Biology Platform Providers to Accelerate Life Science Research and Drug Development

LEUVEN, Belgium–(BUSINESS WIRE)–OMAPiX, a leading provider of spatial omics services and custom data analytics, today announced strategic partnerships with Vizgen®, Inc., Resolve Biosciences, and Ultivue, Inc. As part of the agreements, OMAPiX scientists will use Vizgen’s MERSCOPE® Platform technology, Resolve Biosciences’ Molecular Cartography™ technology, and Ultivue’s InSituPlex® and UltiStacker® technologies to provide customers with standardized, reliable, high-quality spatial transcriptomic and proteomic data and unique insights to accelerate drug development and life science research.